Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CEFTAZIDIME Cause Toxic epidermal necrolysis? 94 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 94 reports of Toxic epidermal necrolysis have been filed in association with CEFTAZIDIME (TAZICEF). This represents 3.0% of all adverse event reports for CEFTAZIDIME.

94
Reports of Toxic epidermal necrolysis with CEFTAZIDIME
3.0%
of all CEFTAZIDIME reports
63
Deaths
38
Hospitalizations

How Dangerous Is Toxic epidermal necrolysis From CEFTAZIDIME?

Of the 94 reports, 63 (67.0%) resulted in death, 38 (40.4%) required hospitalization, and 25 (26.6%) were considered life-threatening.

Is Toxic epidermal necrolysis Listed in the Official Label?

Yes, Toxic epidermal necrolysis is listed as a known adverse reaction in the official FDA drug label for CEFTAZIDIME.

What Other Side Effects Does CEFTAZIDIME Cause?

Drug ineffective (518) Off label use (266) Condition aggravated (228) Septic shock (200) Acute kidney injury (191) Pyrexia (176) Endophthalmitis (128) Multiple organ dysfunction syndrome (124) Neutropenia (123) Drug reaction with eosinophilia and systemic symptoms (121)

What Other Drugs Cause Toxic epidermal necrolysis?

ACETAMINOPHEN (980) LAMOTRIGINE (941) ALLOPURINOL (858) IBUPROFEN (764) SULFAMETHOXAZOLE\TRIMETHOPRIM (592) CIPROFLOXACIN (576) FUROSEMIDE (521) VANCOMYCIN (515) PIPERACILLIN\TAZOBACTAM (490) PEMBROLIZUMAB (444)

Which CEFTAZIDIME Alternatives Have Lower Toxic epidermal necrolysis Risk?

CEFTAZIDIME vs CEFTIBUTEN CEFTAZIDIME vs CEFTOLOZANE\TAZOBACTAM CEFTAZIDIME vs CEFTRIAXONE CEFTAZIDIME vs CEFTRIAXONE\CEFTRIAXONE CEFTAZIDIME vs CEFUROXIME

Related Pages

CEFTAZIDIME Full Profile All Toxic epidermal necrolysis Reports All Drugs Causing Toxic epidermal necrolysis CEFTAZIDIME Demographics